China Insurance Regulator Stresses Thin Profit For Severe Disease Insurance
This article was originally published in PharmAsia News
Executive Summary
The China Insurance Regulatory Commission will ensure slim profits for insurance companies via mechanisms such as scientific pricing, supervision fee reductions, and profit-adjustments.